Coronary artery calcifications and diastolic dysfunction versus visceral fat area in type 1 diabetes: VISCERA study

Christophe E M De Block1, Bharati Shivalkar2, Wouter Goovaerts3

  • 1University of Antwerp, Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Pediatrics (LEMP), Antwerp, Belgium; Department of Endocrinology, Diabetology & Metabolism, Antwerp University Hospital, Edegem, Belgium.

Insights

Visceral adipose tissue (VAT) is linked to coronary artery calcifications (CAC) and diastolic dysfunction in type 1 diabetic patients (T1DM). Early detection of VAT may help reduce cardiovascular risk in this population.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Type 1 diabetic patients (T1DM) have increased cardiovascular disease and mortality risks.
  • Visceral adipose tissue (VAT) accumulation is a potential contributor to cardiovascular complications in T1DM.

Purpose of the Study:

  • To investigate the association between visceral adipose tissue (VAT) and coronary artery calcifications (CAC) in T1DM patients.
  • To determine if VAT contributes to cardiac dysfunction, specifically diastolic dysfunction, in T1DM.

Main Methods:

  • A cross-sectional study involving 118 T1DM patients without prior cardiovascular disease.
  • Coronary artery calcifications (CAC) and visceral adipose tissue (VAT) were quantified using CT scans.
  • Cardiac function was assessed via echocardiography to identify diastolic dysfunction.

Main Results:

  • 42% of T1DM patients had CAC (score ≥10), and 75% exhibited diastolic dysfunction.
  • 46% of patients had significant VAT (≥100cm²), which was associated with higher CAC prevalence (54% vs 31%, p=0.01).
  • Independent predictors for CAC included age, diabetes duration, gender, LDL-cholesterol, and metabolic syndrome. Age, waist circumference, and VAT were linked to diastolic dysfunction.

Conclusions:

  • Excess visceral adipose tissue (VAT) is prevalent in T1DM patients and is associated with both coronary artery calcifications (CAC) and diastolic dysfunction.
  • These findings suggest that VAT plays a significant role in the elevated cardiovascular risk observed in T1DM.
  • Timely assessment and management of VAT may be crucial for mitigating future cardiovascular events in individuals with type 1 diabetes.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
430